Quinapril Tablets USP — Class II drug recall D-409-2014
Terminated recall by Lupin Pharmaceuticals Inc., reported 2014-01-22, distributed nationwide. Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be abo
| Recall number | D-409-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2013-09-17 |
| Classified | 2014-01-10 |
| Reported by FDA | 2014-01-22 |
| Terminated | 2016-05-11 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68180-0554, 68180-0554-03, 68180-0554-09, 68180-0556, 68180-0556-09, 68180-0557, 68180-0557-03, 68180-0557-09, 68180-0558, 68180-0558-03, 68180-0558-09, 68180-0559, 68180-0559-03, 68180-0559-09 |
| Lot numbers | 12/13, 3110358 |
Product
Quinapril Tablets USP, 10 mg, 90 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 United States Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-557-09
Reason for recall
Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-409-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.